This information was received as a part of an extensive mesh litigation submission to medtronic.The fda was notified of this large complaint receipt.Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.If information is provided in the future, a supplemental report will be issued.
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after the implant, the patient experienced recurrence, scarring, and enterocutaneous fistula.Post-operative patient treatment included exploratory laparotomy, closure of enterocutaneous fistula, small bowel resection with anastomosis, left and right rectus abdominis muscle flaps rotated to the trunk, removal of fistula tract, removal of scar to abdomen, and debridement of abdominal wall.
|